BASSADO ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
23Prion disease2

23. Prion disease


Clinical trials : 4 Drugs : 5 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-022233-28-IT
(EUCTR)
20/06/201105/03/2012Fatal familial insomnia: preventive treatment with doxycycline of at risk individuals - Doxycycline in FFI individuals Subjects born between 1958 and 1969 belonging to the Treviso FFI family, tested previously for Prion D178N/129M mutation
MedDRA version: 14.1;Level: SOC;Classification code 10029205;Term: Nervous system disorders;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: BASSADO
INN or Proposed INN: DOXYCYCLINE HYCLATE
IST. DI RICERCHE FARMACOLOG. M. NEGRINULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy
2EUCTR2006-001858-27-IT
(EUCTR)
21/06/200612/04/2007A randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of doxycline administered by oral route in patients affected by Creutzfeldt-Jakob disease. - NDA randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of doxycline administered by oral route in patients affected by Creutzfeldt-Jakob disease. - ND Creutzfeldt-Jakob Disease.
MedDRA version: 9.1;Level: LLT;Classification code 10011384;Term: Creutzfeldt-Jakob disease
Trade Name: BASSADO 10CPS 100MG
INN or Proposed INN: Doxycycline
ISTITUTO NEUROLOGICO CARLO BESTANULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy